Bioassay, which stands for biological assay, is a procedure that measures the potency, efficacy, or toxicity of a substance by observing its effects on living tissues, organisms, or cells. Bioassays are a vital part of scientific research as they provide a direct and measurable understanding of how a substance interacts with living systems. As such, they drive pharmaceutical and biotechnology advancements and accelerate the development of vaccines and targeted therapies.
They are immensely important in drug discovery and development, safety and toxicity testing, biologic and vaccine production, and personalized medicine. These analytical methods are primarily categorized by the testing environment, meaning where the testing takes place along with the nature of the response measured. Following are some of the main categories:
- In Vitro: This test is conducted in an artificial, controlled environment outside a living organism in petri dishes or test tubes. Enzymes, cultured cells, or isolated tissues are utilized to study molecular mechanisms cost-effectively and efficently.
- In Vivo: This test is conducted using living, whole organisms, like plants, or laboratory animals. In vivo assays are critical when evaluating the systematic metabolism, effects, and overall toxicity in a living body.
- Quantitative: Known as a graded assay, quantitative measures the responses that vary in magnitude along with a dose increase. Factors like heart rate, blood pressure, or enzyme inhibition are considered.
- Qualitative: For qualitative assays, the objective is to determine whether a specific biological response occurs or does not occur. Rather than measuring the magnitude of a response, these assays evaluate binary outcomes. Such as survival versus death, or the presence versus absence of a tumor, resulting in an all-or-none determination.
In Vitro and In Vivo Bioassays
In vitro, which translates to “in glass,” and in vivo “within the living” are two different types of assays. Testing for in vitro includes isolated cells or tissues within a controlled environment outside its biological context. In vivo is studying whole, living organisms. There is some debate ethically when weighing what option to use that is based on practical resource limits, ethical mandates, and the need for physiological complexity.
In vivo animal testing comes along with significant moral and ethical considerations regarding the distress and pain of the laboratory animals. A regulatory framework is in place to protect against this by enforcing the 3Rs: replacement, reduction, and refinement. This means that researchers are required to replace the animal with in vitro or computer-based models when possible, reducing the number of animals used and refining procedures to minimize invasiveness and improve animal welfare. Scientific considerations, resource limits, and other practical considerations are also part of what makes one option a better choice over another for a variety of reasons. This has been a heated debate for many years within and outside of the scientific community.
Quantitative vs. Qualitative Bioassays
Quantitative and qualitative are both types of bioassays, but they are used in determining different information. For example, quantitative measures an exact amount or exact concentration or potency. It is directly related to the dosage administered and how that impacts the result. Qualitative bioassays don’t measure concentration. Instead, they measure the presence or absence of a trait, activity, or specific biological effect. The following looks at how these differ in more detail:
- Quantitative Bioassays: A quantitative bioassay is designed to measure the potency or amount of an active substance by evaluating the relationship between dose and biological response. Common endpoints include enzyme activation, receptor binding, and cell death. The results are often compared to a reference standard using statistical analyses to determine relative potency. Common examples or usage of this is to calculate the LD 50, which is a lethal dose for 50% of the population. It is often used to monitor disease progression, test drug dosage, and measure trends to establish baselines or test a hypothesis.
- Qualitative Bioassays: A qualitative bioassay is designed to determine the presence or absence of a specific biological activity, trait, or effect. These assays evaluate categorical outcomes that are difficult or impossible to quantify numerically, such as visible toxicity, abnormal development, or physical deformities. Common examples include determining whether an antibiotic inhibits bacterial growth on a culture plate or whether a substance induces developmental abnormalities in an embryo. Qualitative bioassays are frequently used in early-stage screening, exploratory research, and feasibility studies to identify potential biological effects before more detailed quantitative analyses are performed.
In many cases, these two assays are used together, which is known as a mixed-method approach. The process might begin with a qualitative assay to explore or help identify a target, then the quantitative will measure the prevalence, scale, or determine the exact concentration.
Cell-Based Assays
Cell-based assays are laboratory methods that use living cells to investigate drug activity, biological pathways, and disease mechanisms. They provide an intermediate model between simple biochemical assays performed in vitro and more complex in vivo animal studies. These assays are based on monitoring cellular responses, either functional or structural to external stimuli, such as therapeutic compounds, environmental factors, or genetic modifications. Recent advances in cell-based assay technologies have improved automation, scalability, and analytical capabilities, leading to innovations such as the following:
- AI-Driven Cell Culture: Advanced cell culture platforms incorporate machine learning and robotics to automate routine media exchanges, cell monitoring, and harvesting.
- 3D Cell Models: Cell culture systems have evolved from two-dimensional (2D) monolayer cultures to more physiologically relevant three-dimensional (3D) models, including spheroids and organoids. These models better mimic the structure and function of human tissues, and many automated liquid-handling platforms have been adapted to support their cultivation and analysis.
- High-Content Screening (HCS): This includes the integration of microscopy with image analysis software, allowing researchers to track protein translocation, individual cell health, and morphological changes in real-time.
Applications for cell-based assays innovation and automation include improvements to the entire drug development pipeline, including drug efficacy, toxicity, and biomarker discovery. These advances have also contributed to a significant reduction in late-stage clinical attrition.
Enzyme-Linked Immunosorbent Assay (ELISA) and Receptor Binding Assays
Enzyme-Linked Immunosorbent Assay (ELISA) is an analytical technique that utilizes highly specific antigen-antibody interactions to detect and quantify target substances within a sample. Commonly used in blood testing, ELISA can identify the presence and concentration of analytes such as proteins, antibodies, hormones, and infectious agents. Widely regarded as a gold-standard method in clinical diagnostics, ELISA plays a critical role in the detection of infectious and autoimmune diseases, the measurement of disease biomarkers, and the evaluation of vaccine-induced immune responses and efficacy.
Receptor binding assays are analytical methods used to evaluate the interaction between molecules, known as ligands, and bind to specific proteins on cell membranes. This is often used to test the affinity and efficacy of a pharmaceutical drug. Receptor binding assays are often used in drug discovery and development, and research into cellular mechanisms such as identifying receptor expression levels or understanding cell signaling pathways.
Applications of Bioassays in Drug Efficacy, Toxicology, and Biomarker Discovery
Bioassays play a critical role in supporting the evaluation of drug efficacy, potential toxicology, and biomarker identification and validation. A key application of bioassays is verifying a drug’s mechanism of action (MoA), helping confirm that it interacts with its intended biological target and produces the desired therapeutic effect. By measuring biological activity, bioassays provide insight into how a drug interacts with its target and supports its mechanism of action. They also assess potency by determining the concentration of a substance required to achieve a defined biological response. Beyond direct effects, bioassays can measure downstream cellular and molecular responses, offering a more comprehensive understanding of a drug’s overall biological impact.
In addition to assessing efficacy, bioassays play a vital role in toxicological evaluations by helping determine the safety of a therapeutic candidate. These assays are used to identify potential hazards and adverse biological effects, such as cytotoxicity, endocrine disruption, and genotoxicity. Bioassays can also provide mechanistic insights into toxic responses, support environmental monitoring efforts by evaluating the cumulative effects of multiple compounds, assist with regulatory compliance, and contribute to the development of comprehensive safety profiles before a drug advances to clinical trials.
Bioassays also play an important role in biomarker discovery and validation. By measuring biological activity and cellular responses, these assays enable researchers to correlate specific genes, proteins, or other molecular signatures with disease progression, therapeutic response, or toxicity. This information can support patient stratification, treatment monitoring, and the development of more targeted therapies. This validates targets in controlled environments to bridge disease mechanisms with therapies and enables high-throughput screening to isolate those promising indicators.
Advancements and Best Practices in Bioassay Techniques
Optimizing bioassay performance requires creating protocols that ensure accuracy, precision, and reproducibility. Generally, advancements in these techniques have relied on embracing a combination of standardized reagent controls, robust statistical design, and instrumentation automation. An important advancement in bioassay optimization is the use of Design of Experiments (DoE). Unlike traditional approaches that evaluate one variable at a time, DoE uses statistical software to simultaneously assess the effects of multiple parameters and their interactions. This approach enables researchers to identify critical process variables more efficiently, optimize assay performance, and establish robust operating ranges that support consistent and reproducible results.
Advancements also include standardization for biological components such as cell banking and lot control and automation. In most cases, variability is the result of manual pipetting. Automated liquid handling and plate mapping have assisted in overcoming common issues like volume inconsistencies and edge effects. Statistical analysis on another level is also key and includes parallelism testing and non-linear modeling. Of course, industry-standard frameworks and established national guidelines should also be part of your validation process and assay development, even when implementing innovative techniques in the processes.
Bioassay Methods Are Key and We Can Help
Bioassay techniques and advancements have dramatically accelerated the drug discovery process, improved clinical diagnostics, and continue to ensure environmental safety by delivering highly sensitive, high-throughput testing at reduced cost. There are many bioassay types, all of which serve a purpose uniquely helpful to the pharmaceutical industry. Contact us at BA Sciences to learn more about our bioassay methods, and types. We are ready to work with you today.